Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Champions Oncology, Inc.

Champions Oncology (($CSBR)) has held its Q1 earnings call. Read on for the main highlights of the call. Champions Oncology’s latest earnings call ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CSBR	$4.90	-1.01%	8.80K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CSBR	$4.90	-1.0%	8.80K
3
4
5
6

CSBR

Get Champions Oncology, Inc. Data in Excel

Get Champions Oncology, Inc. Data in Excel